D-0001-2021 Class II Terminated
FDA drug recall D-0001-2021 was initiated by Strides Inc. on Aug 24, 2020 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Jan 11, 2022). Affected quantity: 11,280 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 7, 2020
- Initiation Date
- Aug 24, 2020
- Termination Date
- Jan 11, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 11,280 bottles
Product description
Strides Pharma Inc.Potassium Chloride Extended-Release Tablets, USP 8mEq (600 mg) 100 Tablets Rx Only Manufactured by: Strides Pharma Science Limited Bengaluru -562106 India Distributed by: Strides Pharma Inc., East Brunswick NJ 08816 NDC 64380-860-06
Reason for recall
Failed Dissolution Specifications
Distribution pattern
nationwide
Code information
7240675A; Exp. 12/31/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0001-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026